CLINICAL RESEARCH
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy
an independent marker of sudden death risk in young patients
Lorenzo Monserrat, MD ,
Perry M. Elliott, MD, MRCP, FACC*,*,
Juan R. Gimeno, MD*,
Sanjay Sharma, BSc, MRCP*,
Manuel Penas-Lado, MD and
William J. McKenna, MD, FACC, FESC, FRCP*
* Department of Cardiological Sciences, St. George's Hospital Medical School, London, United Kingdom
Service of Cardiology, Juan Canalejo Hospital, A Coruña, Spain
Manuscript received September 13, 2002;
revised manuscript received January 15, 2003,
accepted February 10, 2003.
* Reprint requests and correspondence: Dr. Perry M. Elliott, Department of Cardiological Sciences, St. George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, United Kingdom. pelliott{at}sghms.ac.uk
OBJECTIVES: The aim of this study was to examine the characteristics of non-sustained ventricular tachycardia (NSVT) episodes during Holter monitoring and to determine their relationship to age and prognosis.
BACKGROUND: It has been suggested that NSVT is only of prognostic importance in patients with hypertrophic cardiomyopathy (HCM) when repetitive, prolonged, or associated with symptoms.
METHODS: We studied 531 patients with HCM (323 male, 39 ± 15 years). All underwent ambulatory electrocardiogram monitoring (41 ± 11 h).
RESULTS: A total of 104 patients (19.6%) had NSVT. The proportion of patients with NSVT increased with age (p = 0.008). Maximum left ventricular wall thickness and left atrial size were greater in patients with NSVT. Mean follow-up was 70 ± 40 months. Sixty-eight patients died, 32 from sudden cardiac death (SCD). Twenty-one patients received an implantable cardioverter defibrillator (ICD). There were four appropriate ICD discharges. In patients 30 years (but not >30), five-year freedom from sudden death was lower in those with NSVT (77.6% [95% confidence interval (CI): 59.8 to 95.4] vs. 94.1% [95% CI: 90.2 to 98.0]; p = 0.003). There was no relation between the duration, frequency, or rate of NSVT runs and prognosis at any age. The odds ratio of sudden death in patients 30 years of age with NSVT was 4.35 (95% CI: 1.54 to 12.28; p = 0.006) compared with 2.16 (95% CI: 0.82 to 5.69; p = 0.1) in patients >30 years of age.
CONCLUSIONS: Non-sustained ventricular tachycardia is associated with a substantial increase in sudden death risk in young patients with HCM. A relation between the frequency, duration, and rate of NSVT episodes could not be demonstrated.
|
Abbreviations and Acronyms
| | CI | | confidence interval | | HCM | | hypertrophic cardiomyopathy | | ICD | | implantable cardioverter defibrillator | | LV | | left ventricular | | NSVT | | non-sustained ventricular tachycardia | | SCD | | sudden cardiac death |
|
This article has been cited by other articles:

|
 |

|
 |
 
I. Christiaans, K. van Engelen, I. M. van Langen, E. Birnie, G. J. Bonsel, P. M. Elliott, and A. A.M. Wilde
Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers
Europace,
January 29, 2010;
(2010):
eup431v1 - eup431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Maron
Contemporary Insights and Strategies for Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
Circulation,
January 26, 2010;
121(3):
445 - 456.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rubinshtein, J. F. Glockner, S. R. Ommen, P. A. Araoz, M. J. Ackerman, P. Sorajja, J. M. Bos, A. J. Tajik, U. S. Valeti, R. A. Nishimura, et al.
Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy
Circ Heart Fail,
January 1, 2010;
3(1):
51 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Christiaans, E. Birnie, I. M. van Langen, K. Y. van Spaendonck-Zwarts, J. P. van Tintelen, M. P. van den Berg, D. E. Atsma, A. T.J.M. Helderman-van den Enden, Y. M. Pinto, J.F. Hermans-van Ast, et al.
The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening
Eur. Heart J.,
December 16, 2009;
(2009)
ehp539v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Gimeno, M. Tome-Esteban, C. Lofiego, J. Hurtado, A. Pantazis, B. Mist, P. Lambiase, W. J. McKenna, and P. M. Elliott
Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy
Eur. Heart J.,
November 1, 2009;
30(21):
2599 - 2605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Decker, J. W. Rossano, E. O. Smith, B. Cannon, S. K. Clunie, C. Gates, J. L. Jefferies, J. J. Kim, J. F. Price, W. J. Dreyer, et al.
Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
J. Am. Coll. Cardiol.,
July 14, 2009;
54(3):
250 - 254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Papadakis, S. Basavarajaiah, J. Rawlins, C. Edwards, J. Makan, S. Firoozi, L. Carby, and S. Sharma
Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes
Eur. Heart J.,
July 2, 2009;
30(14):
1728 - 1735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Maron, J. J. Finley, J. M. Bos, T. H. Hauser, W. J. Manning, T. S. Haas, J. R. Lesser, J. E. Udelson, M. J. Ackerman, and B. J. Maron
Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy
Circulation,
October 7, 2008;
118(15):
1541 - 1549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Elliott and P Spirito
Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice
Heart,
October 1, 2008;
94(10):
1269 - 1275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Saumarez, M. Pytkowski, M. Sterlinski, J. P. Bourke, J. R. Clague, S. M. Cobbe, D. T. Connelly, M. J. Griffith, P. P. McKeown, K. McLeod, et al.
Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy
Eur. Heart J.,
July 1, 2008;
29(13):
1653 - 1661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sen-Chowdhry and W. J. McKenna
Non-invasive risk stratification in hypertrophic cardiomyopathy: don't throw out the baby with the bathwater
Eur. Heart J.,
July 1, 2008;
29(13):
1600 - 1602.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Basavarajaiah, A. Boraita, G. Whyte, M. Wilson, L. Carby, A. Shah, and S. Sharma
Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy.
J. Am. Coll. Cardiol.,
June 10, 2008;
51(23):
2256 - 2262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nazarian and J. A.C. Lima
Cardiovascular Magnetic Resonance for Risk Stratification of Arrhythmia in Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol.,
April 8, 2008;
51(14):
1375 - 1376.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Basavarajaiah, M. Wilson, G. Whyte, A. Shah, W. McKenna, and S. Sharma
Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
J. Am. Coll. Cardiol.,
March 11, 2008;
51(10):
1033 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
e247 - e346.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
746 - 837.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Elliott, J. R. Gimeno, M. T. Tome, J. Shah, D. Ward, R. Thaman, J. Mogensen, and W. J. McKenna
Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy
Eur. Heart J.,
August 2, 2006;
27(16):
1933 - 1941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Spirito and C. Autore
Management of hypertrophic cardiomyopathy.
BMJ,
May 27, 2006;
332(7552):
1251 - 1255.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Enseleit and F. Duru
Long-term continuous external electrocardiographic recording: a review.
Europace,
April 1, 2006;
8(4):
255 - 266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Nugent, P. E.F. Daubeney, P. Chondros, J. B. Carlin, S. D. Colan, M. Cheung, A. M. Davis, C.W. Chow, R. G. Weintraub, and for the National Australian Childhood Cardiomyopat
Clinical Features and Outcomes of Childhood Hypertrophic Cardiomyopathy: Results From a National Population-Based Study
Circulation,
August 30, 2005;
112(9):
1332 - 1338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. D. Binder, M. A. Fifer, M. E. King, and J. R. Stone
Case 26-2005 - A 48-Year-Old Man with Sudden Loss of Consciousness while Jogging
N. Engl. J. Med.,
August 25, 2005;
353(8):
824 - 832.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Adabag, S. A. Casey, M. A. Kuskowski, A. G. Zenovich, and B. J. Maron
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy
J. Am. Coll. Cardiol.,
March 1, 2005;
45(5):
697 - 704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G Katritsis and A.J. Camm
Nonsustained ventricular tachycardia: where do we stand?
Eur. Heart J.,
July 1, 2004;
25(13):
1093 - 1099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Nonsustained VT Predicts Sudden Death in Young HCM Patients
Journal Watch Cardiology,
November 28, 2003;
2003(1128):
3 - 3.
[Full Text]
|
 |
|
|